ELAB exhibits severe financial distress with revenue plummeting 65.5% while liabilities more than doubled and going-concern warnings persist.
The company faces immediate existential threats with dramatic revenue decline coupled with massive liability increases and explicit warnings about operational continuity. Multiple reverse stock splits mentioned in new risk language suggest desperate capital preservation measures, while the stark deterioration in core business metrics indicates potential business model failure.
ELAB's financial position deteriorated dramatically with revenue collapsing from $1.7M to $590K while current liabilities surged 119% to $3.9M, creating a severe liquidity crisis. Despite total assets growing to $12.9M, the company burned through inventory (down 80%) and saw gross profit margins implode from healthy levels to just $185K, while net losses deepened to $7.7M. The combination of plummeting revenue, exploding liabilities, and massive capital expenditure increases ($9K to $442K) alongside rising interest expenses signals a company in acute financial distress struggling to maintain operations.
Capital expenditure jumped 4728.1% — major investment cycle underway; assess returns on deployment.
Interest expense surged 642.7% — significant debt increase or rising rates materially impacting earnings.
Current liabilities surged 119.1% — significant near-term obligations; verify ability to meet short-term debt.
Liabilities grew 115.6% — significant increase in debt or obligations, assess impact on financial flexibility.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Inventory drawn down 80.8% — strong sell-through or deliberate destocking; watch for supply constraints.
Revenue declined 65.5% — significant demand weakness or market share loss warrants investigation.
Asset base grew 43.1% — expansion through organic growth, acquisitions, or capital deployment.
R&D investment increased 40.5% — signals commitment to future product development, though near-term margin impact.
Net income declined 24% — review whether driven by operations, interest costs, or non-recurring items.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →